Delivery Order SPE2DB25D3108-SPE2DB26FPBMR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $47,160. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is due for completion by October 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $16,491.43 and an ultimate completion date of September 29, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $36,293.07. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract is valued at $59,442.23 and carries a firm fixed price structure with completion scheduled for September 11, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $23.9K and is classified as a firm fixed price delivery order with an ultimate completion date of October 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract is valued at $22,680.70 and will be completed by October 30, 2025. The delivery order utilizes firm fixed price terms with no set-aside designation, indicating competitive award through open procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This competitively awarded, firm fixed-price delivery order has a ceiling value of $17,461.55 and an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $67,419.80. The contract is scheduled for completion by October 17, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $65,345.95 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBMRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $10,334.55. This firm fixed price, non-set-aside contract is scheduled for ultimate completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 value through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to support military healthcare systems and other federal medical programs. The contract vehicle demonstrates the company's established capability to fulfill competitive federal procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 10/31/25 |